Search

Your search keyword '"Bayona J"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Bayona J" Remove constraint Author: "Bayona J" Database Unpaywall Remove constraint Database: Unpaywall
90 results on '"Bayona J"'

Search Results

2. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population

3. Cytopenia and Infection Early after Standard of Care Idecabtagene Vicleucel in Multiple Myeloma

4. Multivirus-Specific T-Cell Therapy with Posoleucel (ALVR105) for Refractory Disseminated Adenovirus Infection after Allogeneic HCT

16. New sources for argument: do HLA-C and HLA disparity in adult double umbilical cord blood transplants predict outcomes?

18. Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience

23. Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

29. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis

31. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era

32. Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML

33. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment

35. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects

36. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

40. Sirolimus for treatment of steroid-refractory acute graft-versus-host disease

41. Evaluation of 243 Patients with Myelodysplastic Syndrome (MDS) Referred for Hematopoietic Cell Transplant (HCT) Including Donor Availability and HCT Outcomes.

42. Sirolimus Yields High Response Rates in Hematopoietic Allograft Recipients with Steroid-Refractory Acute Graft-Versus-Host Disease.

45. Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience

46. Administration of Rituximab 375 Mg/m2 on Days +1 and +8 after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Regimens for Patients with Advanced CD20+ Lymphoid Malignancies

47. Hypoalbuminemia (< 3.0 g/dl) and Poor Karnofsky Performance Score (<80) at Day 90 Following Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Are Independent Predictors of Worse Non-Relapse Survival (NRS) and Overall Survival (OS): A Multivariable Analysis Approach of Various Clinical, Laboratory and Pharmacologic Parameters

48. Expanding Global HIV Treatment

Catalog

Books, media, physical & digital resources